Showing results (11-20 of 122) with videos related to
Sort By:
Pageof 13
Clinical Lung Cancer|October 13, 2018
Adjuvant Therapy in Patients With Completely Resected Non-small-cell Lung Cancer: Current Status and PerspectivesRobert Pirker, Martin FilipitsLung Cancer (Amsterdam, Netherlands)|September 3, 2011
Predictive markers in the adjuvant therapy of non-small cell lung cancerMartin Filipits, Robert PirkerWiener Medizinische Wochenschrift (1946)|December 25, 2007
[Biomarkers - the way towards individualized chemotherapy in non-small cell lung cancer (NSCLC)]Sabine Danzinger, Martin FilipitsTranslational Lung Cancer Research|March 26, 2015
Cetuximab in non-small-cell lung cancerRobert Pirker, Martin FilipitsCritical Reviews in Oncology/Hematology|November 27, 2010
Monoclonal antibodies against EGFR in non-small cell lung cancerRobert Pirker, Martin FilipitsTranslational Lung Cancer Research|January 23, 2016
Alectinib in RET-rearranged non-small cell lung cancer-Another progress in precision medicine?Robert Pirker, Martin FilipitsCancer Metastasis Reviews|March 14, 2016
Personalized treatment of advanced non-small-cell lung cancer in routine clinical practiceRobert Pirker, Martin FilipitsCurrent Pharmaceutical Design|January 20, 2009
Targeted therapies in lung cancerRobert Pirker, Martin FilipitsAnticancer Research|April 12, 2003
Low p27Kip1 expression is an independent prognostic factor in gallbladder carcinomaMartin Filipits, Harald Puhalla, Friedrich WrbaClinical Lung Cancer|May 8, 2009
Integrating epidermal growth factor receptor-targeted therapies into platinum-based chemotherapy regimens for newly diagnosed non-small-cell lung cancerRobert Pirker, Wilma Minar, Martin FilipitsPageof 13